Low-density lipoprotein size, pravastatin treatment, and coronary events.

CONTEXT Small low-density lipoprotein (LDL) particle size has been hypothesized to be a risk factor for coronary heart disease (CHD). Animal models link large LDL to atherosclerosis. However, the strong association between small LDL and other risk factors, particularly triglyceride levels, impedes determining whether LDL size independently predicts CHD in humans. OBJECTIVE To examine whether LDL size is an independent predictor of recurrent coronary events in patients with known CHD, as opposed to a marker for other lipid abnormalities. DESIGN AND SETTING Prospective, nested case-control study in the Cholesterol and Recurrent Events (CARE) trial, a randomized placebo-controlled trial of pravastatin conducted in 1989-1996. PARTICIPANTS Survivors of myocardial infarction with typical LDL concentrations (416 cases and 421 controls). MAIN OUTCOME MEASURE Subsequent myocardial infarction or coronary death during the 5-year follow-up, analyzed by quintile of LDL particle size and by treatment group. RESULTS Overall, the mean LDL size was identical in cases and controls (25.6 nm). In patients in the placebo group, large LDL predicted coronary events in models adjusted only for age (relative risk [RR], 1.79; 95% confidence interval [CI], 1.01-3.17) and for age and lipid and nonlipid risk factors (RR, 4.00; 95% CI, 1.81-8.82), comparing those in the highest (mean, 26.6 nm) and lowest (mean, 24.5 nm) quintiles of LDL size. This increased risk was not present in those taking pravastatin (age-adjusted analysis: RR, 0.98; 95% CI, 0.47-2.04; P =.046 for interaction for a difference in the effect of LDL size on coronary events between the placebo and treatment groups; multivariable analysis: RR, 1.33; 95% CI, 0.52-3.38; P =.11 for interaction). CONCLUSIONS Large LDL size was an independent predictor of coronary events in a typical population with myocardial infarction, but the adverse effect was not present among patients who were treated with pravastatin. Identifying patients on the basis of LDL size may not be useful clinically, since effective treatment for elevated LDL cholesterol concentrations also effectively treats risk associated with large LDL.

[1]  S M Grundy,et al.  Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. , 1997, Circulation.

[2]  G. Dagenais,et al.  Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Circulation.

[3]  R. Krauss,et al.  Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. , 1998, The American journal of clinical nutrition.

[4]  J. Hendriks,et al.  Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[5]  R. Krauss,et al.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans. , 1982, Journal of lipid research.

[6]  J. Coresh,et al.  Small, dense low-density lipoprotein particles and coronary heart disease risk: A clear association with uncertain implications. , 1996, JAMA.

[7]  HOMAS,et al.  The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels , 2000 .

[8]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[9]  P. Wilson,et al.  Low density lipoprotein particle size and coronary artery disease. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  J. Ordovás,et al.  Urbanization elicits a more atherogenic lipoprotein profile in carriers of the apolipoprotein A-IV-2 allele than in A-IV-1 homozygotes. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[11]  J. Hokanson,et al.  Characterization of low‐density lipoprotein subclasses: methodologie approaches and clinical relevance , 1994, Current opinion in lipidology.

[12]  P. Wilson,et al.  Effect of Gender, Age, and Lipid Status on Low Density Lipoprotein Su bf raction Distribution: Results from the Framingham Offspring Study , 1987, Arteriosclerosis.

[13]  C. Packard,et al.  Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. , 1994, Atherosclerosis.

[14]  S. Eisenberg,et al.  Plasma triglyceride determines structure-composition in low and high density lipoproteins. , 1984, Arteriosclerosis.

[15]  J. Coresh,et al.  Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. , 1993, Journal of lipid research.

[16]  R. Krauss,et al.  Predominance of large LDL and reduced HDL2 cholesterol in normolipidemic men with coronary artery disease. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[17]  R. Krauss.  Heterogeneity of plasma low‐density lipoproteins and atherosclerosis risk , 1994, Current opinion in lipidology.

[18]  F. Sacks,et al.  Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. , 1997, The Journal of clinical endocrinology and metabolism.

[19]  A. Keech,et al.  Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk Factors: The Prospective Pravastatin Pooling Project , 2000, Circulation.

[20]  T. Lancet,et al.  West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996, The Lancet.

[21]  R. Krauss,et al.  Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. , 1996, JAMA.

[22]  R. S. St. Clair,et al.  Differential effects of isolated lipoproteins from normal and hypercholesterolemic rhesus monkeys on cholesterol esterification and accumulation in arterial smooth muscle cells in culture. , 1978, Biochimica et biophysica acta.

[23]  C. Packard,et al.  Lipoprotein heterogeneity and apolipoprotein B metabolism. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[24]  F. Kahl,et al.  Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. , 1985, Journal of lipid research.

[25]  G. Franceschini,et al.  Pravastatin effectively lowers LDL-cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern , 1994 .

[26]  A. Hamsten,et al.  Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. , 1991, Atherosclerosis.

[27]  P. Macfarlane,et al.  West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996 .

[28]  R. Krauss,et al.  A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. , 1996, JAMA.

[29]  R. Krauss,et al.  Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[30]  R. Krauss,et al.  Defective catabolism and abnormal composition of low-density lipoproteins from mutant pigs with hypercholesterolemia. , 1988, Biochemistry.

[31]  P. Zimmet,et al.  Risk Factors for Coronary Heart Disease in a Population with a High Prevalence of Obesity and Diabetes: A Case-Control Study of the Polynesian Population of Western Samoa3 , 1997, Journal of cardiovascular risk.

[32]  P. Lesnik,et al.  Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. , 1991, Journal of lipid research.

[33]  M. Pfeffer,et al.  VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial , 2000, Circulation.

[34]  G. Pozza,et al.  Smaller, denser LDL particles are not a risk factor for cardiovascular disease in healthy nonagenarian women of the Cremona Population Study. , 1998, Atherosclerosis.

[35]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary , 1998 .

[36]  C. Hedrick,et al.  Lipoprotein and cholesterol metabolism in diet-induced coronary artery atherosclerosis in primates. Role of cholesterol and fatty acids. , 1998, Progress in lipid research.

[37]  M. Laakso,et al.  Men and Women , 1901 .